BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11882355)

  • 21. Fc III receptors (FcRIII) on granulocytes: a specific and sensitive diagnostic test for paroxysmal nocturnal hemoglobinuria (PNH).
    Bessler M; Fehr J
    Eur J Haematol; 1991 Sep; 47(3):179-84. PubMed ID: 1833236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotyping of Paroxysmal Nocturnal Hemoglobinuria (PNH).
    Illingworth AJ; Marinov I; Sutherland DR
    Methods Mol Biol; 2019; 2032():323-354. PubMed ID: 31522427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria.
    Gao W; Wang Z; Bai X; Li Y; Ruan C
    Int J Hematol; 2002 May; 75(4):434-9. PubMed ID: 12041678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria].
    Gao W; Wang Z; Zhou Y
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):740-3. PubMed ID: 11930678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic discrepancies between granulocytic and erythroid lineages in peripheral blood of patients with paroxysmal nocturnal haemoglobinuria.
    Pakdeesuwan K; Wanachiwanawin W; Siripanyaphinyo U; Pattanapanyasat K; Wilairat P; Issaragrisil S
    Eur J Haematol; 2000 Jul; 65(1):8-16. PubMed ID: 10914934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
    Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
    Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of phosphorylated STAT5 in bone marrow hematopoietic stem cells of patients with paroxysmal nocturnal hemoglobinuria before and after in vitro G-CSF or SCF stimulation].
    Ding SX; Fu R; Wang HL; Zhang T; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Guan J; Wang J; Li LJ; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(14):956-9. PubMed ID: 22781567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple flow cytometric assay for routine paroxysmal nocturnal hemoglobinuria testing based on immature reticulocytes and granulocytes.
    Tsagarakis NJ; Paterakis G
    Cytometry B Clin Cytom; 2012 Jul; 82(4):259-63. PubMed ID: 22539359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
    Agarwal R; Chapple P; Brown M; Szer J; Juneja S
    Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes.
    Navenot JM; Muller JY; Blanchard D
    Transfusion; 1998 Apr; 38(4):337-42. PubMed ID: 9595015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria.
    Tseng JE; Hall SE; Howard TA; Ware RE
    Am J Hematol; 1995 Dec; 50(4):244-53. PubMed ID: 7485098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria.
    Gurnari C; Graham AC; Efanov A; Pagliuca S; Durrani J; Awada H; Patel BJ; Lichtin AE; Visconte V; Sekeres MA; Maciejewski JP
    Blood Cells Mol Dis; 2021 Mar; 87():102528. PubMed ID: 33341510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
    Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
    Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.
    Alfinito F; Del Vecchio L; Rocco S; Boccuni P; Musto P; Rotoli B
    Leukemia; 1996 Aug; 10(8):1326-30. PubMed ID: 8709638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of PI (phosphatidylinositol)-anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement-regulatory factor.
    Taguchi R; Funahashi Y; Ikezawa H; Nakashima I
    FEBS Lett; 1990 Feb; 261(1):142-6. PubMed ID: 1689670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minor populations of paroxysmal nocturnal hemoglobinuria-type cells in patients with chronic idiopathic neutropenia.
    Damianaki A; Stagakis E; Mavroudi I; Spanoudakis M; Koutala H; Papadogiannis F; Kanellou P; Pontikoglou C; Papadaki HA
    Eur J Haematol; 2016 Dec; 97(6):538-546. PubMed ID: 27124520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin.
    Brodsky RA; Mukhina GL; Li S; Nelson KL; Chiurazzi PL; Buckley JT; Borowitz MJ
    Am J Clin Pathol; 2000 Sep; 114(3):459-66. PubMed ID: 10989647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes.
    Hanaoka N; Nakakuma H; Horikawa K; Nagakura S; Tsuzuki Y; Shimanuki M; Kojima K; Yonemura Y; Kawaguchi T
    Br J Haematol; 2009 Sep; 146(5):538-45. PubMed ID: 19594748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.